ClinicalTrials.gov record
RELY-ABLE Long Term Multi-center Extension of Dabigatran Treatment in Patients With Atrial Fibrillation Who Completed RE-LY Trial
ClinicalTrials.gov ID: NCT00808067
Public ClinicalTrials.gov record NCT00808067. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
RELY-ABLE Long Term Multi-center Extension of Dabigatran Treatment in Patients With Atrial Fibrillation Who Completed the RE-LY Trial and a Cluster Randomised Trial to Assess the Effect of a Knowledge Translation Intervention on Patient Outcomes
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purposes of this study are: 1. To evaluate the long-term safety of dabigatran etexilate 2. To assess the effect of a knowledge translation intervention on patient outcomes
Study identification
- NCT ID
- NCT00808067
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 5,897 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 2008 (Type not available)
- Primary completion
- Dec 2012 (Actual)
- Completion
- Dec 2012 (Actual)
- Last update posted
- Jun 9, 2014
2008 – 2012
United States locations
- U.S. sites
- 216
- U.S. states
- 38
- U.S. cities
- 188
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| 1160.71.0046 Boehringer Ingelheim Investigational Site | Birmingham | Alabama | — | — |
| 1160.71.0057 Boehringer Ingelheim Investigational Site | Birmingham | Alabama | — | — |
| 1160.71.0211 Boehringer Ingelheim Investigational Site | Birmingham | Alabama | — | — |
| 1160.71.0115 Boehringer Ingelheim Investigational Site | Mobile | Alabama | — | — |
| 1160.71.0104 Boehringer Ingelheim Investigational Site | Lake Havasu City | Arizona | — | — |
| 1160.71.0185 Boehringer Ingelheim Investigational Site | Tucson | Arizona | — | — |
| 1160.71.0038 Boehringer Ingelheim Investigational Site | Hot Springs | Arkansas | — | — |
| 1160.71.0302 Boehringer Ingelheim Investigational Site | Jonesboro | Arkansas | — | — |
| 1160.71.0191 Boehringer Ingelheim Investigational Site | Little Rock | Arkansas | — | — |
| 1160.71.0213 Boehringer Ingelheim Investigational Site | Little Rock | Arkansas | — | — |
| 1160.71.0441 Boehringer Ingelheim Investigational Site | Carmichael | California | — | — |
| 1160.71.0333 Boehringer Ingelheim Investigational Site | Fullerton | California | — | — |
| 1160.71.0384 Boehringer Ingelheim Investigational Site | La Jolla | California | — | — |
| 1160.71.0246 Boehringer Ingelheim Investigational Site | Lancaster | California | — | — |
| 1160.71.0070 Boehringer Ingelheim Investigational Site | Merced | California | — | — |
| 1160.71.0349 Boehringer Ingelheim Investigational Site | Oakland | California | — | — |
| 1160.71.0016 Boehringer Ingelheim Investigational Site | Oceanside | California | — | — |
| 1160.71.0459 Boehringer Ingelheim Investigational Site | Pasadena | California | — | — |
| 1160.71.0270 Boehringer Ingelheim Investigational Site | Poway | California | — | — |
| 1160.71.0135 Boehringer Ingelheim Investigational Site | Riverside | California | — | — |
| 1160.71.0300 Boehringer Ingelheim Investigational Site | Sacramento | California | — | — |
| 1160.71.0284 Boehringer Ingelheim Investigational Site | San Diego | California | — | — |
| 1160.71.0379 Boehringer Ingelheim Investigational Site | Walnut Creek | California | — | — |
| 1160.71.0321 Boehringer Ingelheim Investigational Site | Colorado Springs | Colorado | — | — |
| 1160.71.0449 Boehringer Ingelheim Investigational Site | Colorado Springs | Colorado | — | — |
| 1160.71.0360 Boehringer Ingelheim Investigational Site | Denver | Colorado | — | — |
| 1160.71.0413 Boehringer Ingelheim Investigational Site | Denver | Colorado | — | — |
| 1160.71.0362 Boehringer Ingelheim Investigational Site | Fort Collins | Colorado | — | — |
| 1160.71.0278 Boehringer Ingelheim Investigational Site | Bridgeport | Connecticut | — | — |
| 1160.71.0482 Boehringer Ingelheim Investigational Site | Guilford | Connecticut | — | — |
| 1160.71.0382 Boehringer Ingelheim Investigational Site | Boynton Beach | Florida | — | — |
| 1160.71.0056 Boehringer Ingelheim Investigational Site | Brandon | Florida | — | — |
| 1160.71.0296 Boehringer Ingelheim Investigational Site | Clearwater | Florida | — | — |
| 1160.71.0327 Boehringer Ingelheim Investigational Site | Coral Springs | Florida | — | — |
| 1160.71.0376 Boehringer Ingelheim Investigational Site | Daytona Beach | Florida | — | — |
| 1160.71.0074 Boehringer Ingelheim Investigational Site | Fort Myers | Florida | — | — |
| 1160.71.0089 Boehringer Ingelheim Investigational Site | Jacksonville | Florida | — | — |
| 1160.71.0232 Boehringer Ingelheim Investigational Site | Jacksonville | Florida | — | — |
| 1160.71.0427 Boehringer Ingelheim Investigational Site | Jacksonville | Florida | — | — |
| 1160.71.0012 Boehringer Ingelheim Investigational Site | Lakeland | Florida | — | — |
| 1160.71.0034 Boehringer Ingelheim Investigational Site | Miami | Florida | — | — |
| 1160.71.0227 Boehringer Ingelheim Investigational Site | Orlando | Florida | — | — |
| 1160.71.0095 Boehringer Ingelheim Investigational Site | Ormond Beach | Florida | — | — |
| 1160.71.0037 Boehringer Ingelheim Investigational Site | Pensacola | Florida | — | — |
| 1160.71.0137 Boehringer Ingelheim Investigational Site | Port Charlotte | Florida | — | — |
| 1160.71.0417 Boehringer Ingelheim Investigational Site | Port Charlotte | Florida | — | — |
| 1160.71.0332 Boehringer Ingelheim Investigational Site | Rockledge | Florida | — | — |
| 1160.71.0385 Boehringer Ingelheim Investigational Site | Sarasota | Florida | — | — |
| 1160.71.0015 Boehringer Ingelheim Investigational Site | St. Petersburg | Florida | — | — |
| 1160.71.0339 Boehringer Ingelheim Investigational Site | St. Petersburg | Florida | — | — |
| 1160.71.0019 Boehringer Ingelheim Investigational Site | Vero Beach | Florida | — | — |
| 1160.71.0159 Boehringer Ingelheim Investigational Site | Atlanta | Georgia | — | — |
| 1160.71.0021 Boehringer Ingelheim Investigational Site | Augusta | Georgia | — | — |
| 1160.71.0161 Boehringer Ingelheim Investigational Site | Conyers | Georgia | — | — |
| 1160.71.0218 Boehringer Ingelheim Investigational Site | Cicero | Illinois | — | — |
| 1160.71.0438 Boehringer Ingelheim Investigational Site | Maywood | Illinois | — | — |
| 1160.71.0331 Boehringer Ingelheim Investigational Site | Melrose Park | Illinois | — | — |
| 1160.71.0364 Boehringer Ingelheim Investigational Site | Normal | Illinois | — | — |
| 1160.71.0109 Boehringer Ingelheim Investigational Site | North Chicago | Illinois | — | — |
| 1160.71.0152 Boehringer Ingelheim Investigational Site | Oak Lawn | Illinois | — | — |
| 1160.71.0198 Boehringer Ingelheim Investigational Site | Rockford | Illinois | — | — |
| 1160.71.0433 Boehringer Ingelheim Investigational Site | Winfield | Illinois | — | — |
| 1160.71.0377 Boehringer Ingelheim Investigational Site | Fort Wayne | Indiana | — | — |
| 1160.71.0288 Boehringer Ingelheim Investigational Site | Indianapolis | Indiana | — | — |
| 1160.71.0352 Boehringer Ingelheim Investigational Site | Indianapolis | Indiana | — | — |
| 1160.71.0436 Boehringer Ingelheim Investigational Site | Indianapolis | Indiana | — | — |
| 1160.71.0235 Boehringer Ingelheim Investigational Site | South Bend | Indiana | — | — |
| 1160.71.0268 Boehringer Ingelheim Investigational Site | Dubuque | Iowa | — | — |
| 1160.71.0001 Boehringer Ingelheim Investigational Site | West Des Moines | Iowa | — | — |
| 1160.71.0357 Boehringer Ingelheim Investigational Site | West Des Moines | Iowa | — | — |
| 1160.71.0422 Boehringer Ingelheim Investigational Site | Lexington | Kentucky | — | — |
| 1160.71.0178 Boehringer Ingelheim Investigational Site | Louisville | Kentucky | — | — |
| 1160.71.0397 Boehringer Ingelheim Investigational Site | Louisville | Kentucky | — | — |
| 1160.71.0310 Boehringer Ingelheim Investigational Site | Owensboro | Kentucky | — | — |
| 1160.71.0144 Boehringer Ingelheim Investigational Site | Baton Rouge | Louisiana | — | — |
| 1160.71.0018 Boehringer Ingelheim Investigational Site | Lafayette | Louisiana | — | — |
| 1160.71.0132 Boehringer Ingelheim Investigational Site | New Iberia | Louisiana | — | — |
| 1160.71.0096 Boehringer Ingelheim Investigational Site | Auburn | Maine | — | — |
| 1160.71.0114 Boehringer Ingelheim Investigational Site | Annapolis | Maryland | — | — |
| 1160.71.0023 Boehringer Ingelheim Investigational Site | Baltimore | Maryland | — | — |
| 1160.71.0047 Boehringer Ingelheim Investigational Site | Baltimore | Maryland | — | — |
| 1160.71.0079 Boehringer Ingelheim Investigational Site | Baltimore | Maryland | — | — |
| 1160.71.0186 Boehringer Ingelheim Investigational Site | Baltimore | Maryland | — | — |
| 1160.71.0194 Boehringer Ingelheim Investigational Site | Baltimore | Maryland | — | — |
| 1160.71.0255 Boehringer Ingelheim Investigational Site | Bel Air | Maryland | — | — |
| 1160.71.0398 Boehringer Ingelheim Investigational Site | Columbia | Maryland | — | — |
| 1160.71.0177 Boehringer Ingelheim Investigational Site | Rockville | Maryland | — | — |
| 1160.71.0073 Boehringer Ingelheim Investigational Site | Salisbury | Maryland | — | — |
| 1160.71.0207 Boehringer Ingelheim Investigational Site | Salisbury | Maryland | — | — |
| 1160.71.0196 Boehringer Ingelheim Investigational Site | Takoma Park | Maryland | — | — |
| 1160.71.0187 Boehringer Ingelheim Investigational Site | Towson | Maryland | — | — |
| 1160.71.0052 Boehringer Ingelheim Investigational Site | Westminster | Maryland | — | — |
| 1160.71.0443 Boehringer Ingelheim Investigational Site | Haverhill | Massachusetts | — | — |
| 1160.71.0452 Boehringer Ingelheim Investigational Site | Haverhill | Massachusetts | — | — |
| 1160.71.0029 Boehringer Ingelheim Investigational Site | Natick | Massachusetts | — | — |
| 1160.71.0003 Boehringer Ingelheim Investigational Site | North Dartmouth | Massachusetts | — | — |
| 1160.71.0308 Boehringer Ingelheim Investigational Site | Worcester | Massachusetts | — | — |
| 1160.71.0154 Boehringer Ingelheim Investigational Site | Grand Blanc | Michigan | — | — |
| 1160.71.0205 Boehringer Ingelheim Investigational Site | Lapeer | Michigan | — | — |
| 1160.71.0279 Boehringer Ingelheim Investigational Site | Muskegon | Michigan | — | — |
| 1160.71.0445 Boehringer Ingelheim Investigational Site | Petoskey | Michigan | — | — |
| 1160.71.0274 Boehringer Ingelheim Investigational Site | Rochester Hills | Michigan | — | — |
| 1160.71.0165 Boehringer Ingelheim Investigational Site | Saginaw | Michigan | — | — |
| 1160.71.0020 Boehringer Ingelheim Investigational Site | Troy | Michigan | — | — |
| 1160.71.0188 Boehringer Ingelheim Investigational Site | Ypsilanti | Michigan | — | — |
| 1160.71.0202 Boehringer Ingelheim Investigational Site | Minneapolis | Minnesota | — | — |
| 1160.71.0101 Boehringer Ingelheim Investigational Site | Saint Paul | Minnesota | — | — |
| 1160.71.0086 Boehringer Ingelheim Investigational Site | Gulfport | Mississippi | — | — |
| 1160.71.0119 Boehringer Ingelheim Investigational Site | Tupelo | Mississippi | — | — |
| 1160.71.0055 Boehringer Ingelheim Investigational Site | Columbia | Missouri | — | — |
| 1160.71.0257 Boehringer Ingelheim Investigational Site | Kansas City | Missouri | — | — |
| 1160.71.0336 Boehringer Ingelheim Investigational Site | Saint Charles | Missouri | — | — |
| 1160.71.0249 Boehringer Ingelheim Investigational Site | St Louis | Missouri | — | — |
| 1160.71.0027 Boehringer Ingelheim Investigational Site | Kalispell | Montana | — | — |
| 1160.71.0110 Boehringer Ingelheim Investigational Site | Omaha | Nebraska | — | — |
| 1160.71.0346 Boehringer Ingelheim Investigational Site | Henderson | Nevada | — | — |
| 1160.71.0430 Boehringer Ingelheim Investigational Site | Las Vegas | Nevada | — | — |
| 1160.71.0142 Boehringer Ingelheim Investigational Site | Browns Mills | New Jersey | — | — |
| 1160.71.0221 Boehringer Ingelheim Investigational Site | Cherry Hill | New Jersey | — | — |
| 1160.71.0248 Boehringer Ingelheim Investigational Site | Flemington | New Jersey | — | — |
| 1160.71.0478 Boehringer Ingelheim Investigational Site | Oakland | New Jersey | — | — |
| 1160.71.0392 Boehringer Ingelheim Investigational Site | Ocean City | New Jersey | — | — |
| 1160.71.0254 Boehringer Ingelheim Investigational Site | Westwood | New Jersey | — | — |
| 1160.71.0472 Boehringer Ingelheim Investigational Site | Woodland Park | New Jersey | — | — |
| 1160.71.0476 Boehringer Ingelheim Investigational Site | Albany | New York | — | — |
| 1160.71.0044 Boehringer Ingelheim Investigational Site | Cortlandt Manor | New York | — | — |
| 1160.71.0229 Boehringer Ingelheim Investigational Site | Mineola | New York | — | — |
| 1160.71.0451 Boehringer Ingelheim Investigational Site | Mineola | New York | — | — |
| 1160.71.0183 Boehringer Ingelheim Investigational Site | New Rochelle | New York | — | — |
| 1160.71.0210 Boehringer Ingelheim Investigational Site | Northport | New York | — | — |
| 1160.71.0075 Boehringer Ingelheim Investigational Site | Poughkeepsie | New York | — | — |
| 1160.71.0113 Boehringer Ingelheim Investigational Site | The Bronx | New York | — | — |
| 1160.71.0281 Boehringer Ingelheim Investigational Site | The Bronx | New York | — | — |
| 1160.71.0414 Boehringer Ingelheim Investigational Site | Troy | New York | — | — |
| 1160.71.0356 Boehringer Ingelheim Investigational Site | Watertown | New York | — | — |
| 1160.71.0064 Boehringer Ingelheim Investigational Site | Yonkers | New York | — | — |
| 1160.71.0353 Boehringer Ingelheim Investigational Site | Asheville | North Carolina | — | — |
| 1160.71.0080 Boehringer Ingelheim Investigational Site | Charlotte | North Carolina | — | — |
| 1160.71.0350 Boehringer Ingelheim Investigational Site | Gastonia | North Carolina | — | — |
| 1160.71.0173 Boehringer Ingelheim Investigational Site | High Point | North Carolina | — | — |
| 1160.71.0006 Boehringer Ingelheim Investigational Site | Pinehurst | North Carolina | — | — |
| 1160.71.0002 Boehringer Ingelheim Investigational Site | Statesville | North Carolina | — | — |
| 1160.71.0069 Boehringer Ingelheim Investigational Site | Statesville | North Carolina | — | — |
| 1160.71.0102 Boehringer Ingelheim Investigational Site | Grand Forks | North Dakota | — | — |
| 1160.71.0222 Boehringer Ingelheim Investigational Site | Jamestown | North Dakota | — | — |
| 1160.71.0203 Boehringer Ingelheim Investigational Site | Akron | Ohio | — | — |
| 1160.71.0434 Boehringer Ingelheim Investigational Site | Canal Fulton | Ohio | — | — |
| 1160.71.0402 Boehringer Ingelheim Investigational Site | Cincinnati | Ohio | — | — |
| 1160.71.0426 Boehringer Ingelheim Investigational Site | Cincinnati | Ohio | — | — |
| 1160.71.0479 Boehringer Ingelheim Investigational Site | Cincinnati | Ohio | — | — |
| 1160.71.0263 Boehringer Ingelheim Investigational Site | Cleveland | Ohio | — | — |
| 1160.71.0480 Boehringer Ingelheim Investigational Site | Cleveland | Ohio | — | — |
| 1160.71.0267 Boehringer Ingelheim Investigational Site | Columbus | Ohio | — | — |
| 1160.71.0035 Boehringer Ingelheim Investigational Site | Dayton | Ohio | — | — |
| 1160.71.0150 Boehringer Ingelheim Investigational Site | Fairview Park | Ohio | — | — |
| 1160.71.0201 Boehringer Ingelheim Investigational Site | Kettering | Ohio | — | — |
| 1160.71.0223 Boehringer Ingelheim Investigational Site | Lorain | Ohio | — | — |
| 1160.71.0214 Boehringer Ingelheim Investigational Site | Lyndhurst | Ohio | — | — |
| 1160.71.0275 Boehringer Ingelheim Investigational Site | Sandusky | Ohio | — | — |
| 1160.71.0103 Boehringer Ingelheim Investigational Site | Westlake | Ohio | — | — |
| 1160.71.0435 Boehringer Ingelheim Investigational Site | Tulsa | Oklahoma | — | — |
| 1160.71.0139 Boehringer Ingelheim Investigational Site | Corvallis | Oregon | — | — |
| 1160.71.0325 Boehringer Ingelheim Investigational Site | Eugene | Oregon | — | — |
| 1160.71.0133 Boehringer Ingelheim Investigational Site | Springfield | Oregon | — | — |
| 1160.71.0301 Boehringer Ingelheim Investigational Site | Allentown | Pennsylvania | — | — |
| 1160.71.0295 Boehringer Ingelheim Investigational Site | Camp Hill | Pennsylvania | — | — |
| 1160.71.0294 Boehringer Ingelheim Investigational Site | Hershey | Pennsylvania | — | — |
| 1160.71.0369 Boehringer Ingelheim Investigational Site | Jenkintown | Pennsylvania | — | — |
| 1160.71.0431 Boehringer Ingelheim Investigational Site | Lancaster | Pennsylvania | — | — |
| 1160.71.0168 Boehringer Ingelheim Investigational Site | Langhorne | Pennsylvania | — | — |
| 1160.71.0293 Boehringer Ingelheim Investigational Site | Meadowbrook | Pennsylvania | — | — |
| 1160.71.0394 Boehringer Ingelheim Investigational Site | Norristown | Pennsylvania | — | — |
| 1160.71.0466 Boehringer Ingelheim Investigational Site | Pittsburgh | Pennsylvania | — | — |
| 1160.71.0208 Boehringer Ingelheim Investigational Site | Sellersville | Pennsylvania | — | — |
| 1160.71.0465 Boehringer Ingelheim Investigational Site | Uniontown | Pennsylvania | — | — |
| 1160.71.0032 Boehringer Ingelheim Investigational Site | Wynnewood | Pennsylvania | — | — |
| 1160.71.0067 Boehringer Ingelheim Investigational Site | Wyomissing | Pennsylvania | — | — |
| 1160.71.0007 Boehringer Ingelheim Investigational Site | Beaufort | South Carolina | — | — |
| 1160.71.0383 Boehringer Ingelheim Investigational Site | Charleston | South Carolina | — | — |
| 1160.71.0313 Boehringer Ingelheim Investigational Site | Greenville | South Carolina | — | — |
| 1160.71.0166 Boehringer Ingelheim Investigational Site | Spartanburg | South Carolina | — | — |
| 1160.71.0008 Boehringer Ingelheim Investigational Site | Summerville | South Carolina | — | — |
| 1160.71.0084 Boehringer Ingelheim Investigational Site | Chattanooga | Tennessee | — | — |
| 1160.71.0474 Boehringer Ingelheim Investigational Site | Clinton | Tennessee | — | — |
| 1160.71.0062 Boehringer Ingelheim Investigational Site | Germantown | Tennessee | — | — |
| 1160.71.0370 Boehringer Ingelheim Investigational Site | Johnson City | Tennessee | — | — |
| 1160.71.0395 Boehringer Ingelheim Investigational Site | Nashville | Tennessee | — | — |
| 1160.71.0129 Boehringer Ingelheim Investigational Site | Austin | Texas | — | — |
| 1160.71.0410 Boehringer Ingelheim Investigational Site | Austin | Texas | — | — |
| 1160.71.0156 Boehringer Ingelheim Investigational Site | Dallas | Texas | — | — |
| 1160.71.0315 Boehringer Ingelheim Investigational Site | Fort Worth | Texas | — | — |
| 1160.71.0447 Boehringer Ingelheim Investigational Site | Houston | Texas | — | — |
| 1160.71.0483 Boehringer Ingelheim Investigational Site | Killeen | Texas | — | — |
| 1160.71.0335 Boehringer Ingelheim Investigational Site | Lubbock | Texas | — | — |
| 1160.71.0269 Boehringer Ingelheim Investigational Site | San Antonio | Texas | — | — |
| 1160.71.0307 Boehringer Ingelheim Investigational Site | San Antonio | Texas | — | — |
| 1160.71.0285 Boehringer Ingelheim Investigational Site | San Marcos | Texas | — | — |
| 1160.71.0367 Boehringer Ingelheim Investigational Site | Tyler | Texas | — | — |
| 1160.71.0453 Boehringer Ingelheim Investigational Site | Charlottesville | Virginia | — | — |
| 1160.71.0053 Boehringer Ingelheim Investigational Site | Chesapeake | Virginia | — | — |
| 1160.71.0428 Boehringer Ingelheim Investigational Site | Fredericksburg | Virginia | — | — |
| 1160.71.0311 Boehringer Ingelheim Investigational Site | Harrisonburg | Virginia | — | — |
| 1160.71.0292 Boehringer Ingelheim Investigational Site | Newport News | Virginia | — | — |
| 1160.71.0220 Boehringer Ingelheim Investigational Site | Salem | Virginia | — | — |
| 1160.71.0224 Boehringer Ingelheim Investigational Site | Suffolk | Virginia | — | — |
| 1160.71.0317 Boehringer Ingelheim Investigational Site | Winchester | Virginia | — | — |
| 1160.71.0050 Boehringer Ingelheim Investigational Site | Bellingham | Washington | — | — |
| 1160.71.0040 Boehringer Ingelheim Investigational Site | Burien | Washington | — | — |
| 1160.71.0250 Boehringer Ingelheim Investigational Site | Spokane | Washington | — | — |
| 1160.71.0256 Boehringer Ingelheim Investigational Site | Tacoma | Washington | — | — |
| 1160.71.0024 Boehringer Ingelheim Investigational Site | Wenatchee | Washington | — | — |
| 1160.71.0169 Boehringer Ingelheim Investigational Site | Clarksburg | West Virginia | — | — |
| 1160.71.0365 Boehringer Ingelheim Investigational Site | Huntington | West Virginia | — | — |
| 1160.71.0099 Boehringer Ingelheim Investigational Site | Madison | Wisconsin | — | — |
| 1160.71.0072 Boehringer Ingelheim Investigational Site | Milwaukee | Wisconsin | — | — |
| 1160.71.0461 Boehringer Ingelheim Investigational Site | Milwaukee | Wisconsin | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 351 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00808067, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 9, 2014 · Synced Oct 30, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00808067 live on ClinicalTrials.gov.